NCT02257645View on ClinicalTrials.gov

Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks

UnknownOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

September 30, 2016

Conditions
DiphtheriaTetanusPertussisHepatitis BHaemophilus Influenza Type B
Sponsors

Lead Sponsor

LG Life Sciences
All Listed Sponsors
lead

LG Life Sciences

INDUSTRY